QuikRead U-ALB

Slightly elevated urine albumin concentration, microalbuminuria (U-ALB), is a warning sign of eventual renal damage or cardiovascular disease. QuikRead U-ALB is a reliable test for the detection of microalbuminuria and it provides quantitative results within minutes, providing results as accurate as clinical laboratory tests. The QuikRead U-ALB is especially suitable for monitoring diabetic patients and for regular screening of those most at risk of developing renal disease or kidney damage.

The QuikRead U-ALB quantitative test provides you with

Reliability

Reproducible quantitative U-ALB results within the range of 5 – 150 mg/l
Results as accurate as those obtained by central laboratory
Concentrations up to 40 g/l do not adversely affect the test result

Fast results

Results are available within three minutes

Ease of use

Simple test procedure requires no special training
Built-in calibration, no pipetting steps

Test results should never be used alone, without a complete clinical evaluation.

QuikRead U-ALB is not registered in the USA.

Technical data

Products available	06014 QuikRead U-ALB kit, 50 tests
Use	For in vitro diagnostic use, IVD CE
Method	Immunoturbidimetric
Sample type	Urine
Instrument information	QuikRead 101
Measurement time	Within minutes
Reading of the result	Instrument read
Storage	2 – 8 °C
Additionally needed	QuikRead 101 Instrument 06078 Buffer dispenser 1 ml 05560 or QuikRead101 instrument with 1 ml dispenser 06040 Capillaries 20 µl 50 pcs 67962 Plungers 50 pcs 67966 Urine Albumin Control 67881
Country of origin	Finland
Registration	Not registered in the USA
Registered trademark	QuikRead is a registered trademark of Aidian Oy

About microalbuminuria

Nephropathy is one of the most common complications of diabetes, and it is internationally recommended that diabetics should be monitored for incipient nephropathy¹. Since microalbuminuria is suggestive of incipient nephropathy, diabetics should have regular urinary albumin (U-ALB) measurements. The prompt detection of microalbuminuria is important because early intervention can halt and even reverse the progression of nephropathy. As hypertensive individuals may also develop microalbuminuria, they too benefit from regular monitoring of urinary albumin concentration².

References

Viberti GC, Mogensen CE, Passa P et al. St Vincent declaration, 1994: Guideline for the prevention of diabetic renal failure.
Bigazzi R, Bianchi S, Baldari D and Campese V. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertension, 1998; 16, 1325 – 1333.